Arrowhead Pharmaceuticals Aktie
13,96
EUR
-0,79
EUR
-5,32
%
16,06
USD
-0,78
USD
-4,63
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
12.02.18 | Arrowhead Pharmaceuticals Neutral | Cantor Fitzgerald | |
12.02.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
05.01.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
30.11.16 | Arrowhead Pharmaceuticals Mkt Perform | William Blair | |
30.11.16 | Arrowhead Pharmaceuticals Hold | Cantor Fitzgerald | |
30.11.16 | Arrowhead Pharmaceuticals Neutral | Chardan Capital Markets | |
09.10.14 | Arrowhead Pharmaceuticals Sector Perform | RBC Capital Markets |
Werbung
Werbung